Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

744
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
744
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

47
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
47
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.1K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
Time Course of Drug Effect01:14

Time Course of Drug Effect

1.8K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.8K
Drug Regulation01:25

Drug Regulation

1.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcium ion-mediated silk bulk materials with adaptive mechanics and intrinsic osteogenic activity for bone regeneration.

Acta biomaterialia·2026
Same author

SLC6A8-centered placental molecular signature predicts fetal growth restriction via machine learning and single-cell analysis.

Reproductive biology·2026
Same author

Integrated multi-omics analysis reveals the molecular mechanism of tuber morphogenesis under different planting densities in yam (<i>Dioscorea opposita</i> Thunb.).

Frontiers in plant science·2026
Same author

Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China.

Future oncology (London, England)·2026
Same author

Mapping the Causal Landscape of Psoriasis: A Systematic Mendelian Randomization Evidence Synthesis and Development of the MR-PsO Atlas Platform.

Experimental dermatology·2026
Same author

Correction: Spatial transcriptomics reveals Inhba/Smad2/E2f4 axis in Lrp2<sup>high</sup> thecal cell proliferation in androgen-induced PCOS mice.

Frontiers in cell and developmental biology·2026

Related Experiment Video

Updated: May 12, 2025

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.1K

Disproportionality analysis of drug-induced erectile dysfunction using FAERS database.

Xiaona Tian1, Dongqiang Luo2,3, Wenling Zeng4

  • 1Department of Medical Oncology, Zhongshan City People's Hospital, Zhongshan, China.

Scientific Reports
|May 6, 2025
PubMed
Summary

This study identified 28 drugs linked to Drug-Induced Erectile Dysfunction (DIED) risk using FAERS data. A new DIED risk platform was developed, highlighting potential concerns like omeprazole and antihypertensives.

Keywords:
Disproportionality analysisDrug surveillanceDrug-Induced erectile dysfunctionMultivariate logistic regression

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

13.8K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K

Related Experiment Videos

Last Updated: May 12, 2025

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.1K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
00:05

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

13.8K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.5K

Area of Science:

  • Pharmacovigilance
  • Drug Safety
  • Computational Toxicology

Background:

  • Drug-Induced Erectile Dysfunction (DIED) poses a significant health concern.
  • Systematic identification of drugs causing DIED is crucial for patient safety.
  • Existing risk assessment tools for DIED are limited.

Purpose of the Study:

  • To systematically identify drugs associated with DIED risk.
  • To construct and provide a free DIED risk assessment platform.
  • To analyze drug-induced erectile dysfunction onset times and outcomes.

Main Methods:

  • Utilized the FAERS database to identify DIED cases.
  • Employed disproportionality analysis (ROR, PRR, BCPNN, EBGM) to detect drug signals.
  • Applied multivariate logistic regression to assess independent risk factors and confounding variables.

Main Results:

  • Identified 67 target drugs as primary suspects in DIED events.
  • Detected 28 drugs with significant DIED risk signals.
  • Confirmed 23 drugs as independent risk factors for DIED, including previously unreported ones like omeprazole and antihypertensives.

Conclusions:

  • This study successfully identified 28 drugs associated with DIED risk.
  • The developed DIED risk assessment platform offers a valuable resource for clinicians and researchers.
  • Findings highlight the need for clinical vigilance regarding specific drugs and their potential to cause erectile dysfunction.